News Archives
The George Washington University (GW) School of Medicine and Health Sciences celebrated faculty members who recently were granted Emeriti Faculty status, earned promotions or tenure, or who reached significant service milestones at the school.
Mandi Pratt-Chapman, PhD ’20, associate center director for patient-centered initiatives and health equity at the George Washington University (GW) Cancer Center and associate professor of medicine at the GW School of Medicine and Health Sciences, was awarded one of three 2021 National Institutes of Health Sexual and Gender Minority Research Investigator Awards.
At the American College of Surgeons (ACS) Clinical Congress 2021, Anton N. Sidawy, MD, MPH ’99, professor and Lewis B. Saltz Chair of the Department of Surgery at the George Washington University School of Medicine and Health Sciences, was elected to the position of chair of the ACS Board of Regents.
Donald S. Karcher, MD, professor of pathology at the George Washington University (GW) School of Medicine and Health Sciences and chief of Flow Cytometry at the GW Medical Faculty Associates, has added another title to his roster: president-elect of the College of American Pathologists.
To fill a growing need for health care professionals who can effectively screen, diagnose, and treat individuals with substance use disorder, an interprofessional team from the George Washington University School of Medicine and Health Sciences, the School of Nursing, and the Milken Institute School of Public Health have created Project RESULT: Rethinking Substance Use Disorder Practitioner Learning and Teaching.
The 2021 list of George Washington University School of Medicine and Health Sciences faculty members who have received promotions and tenure, as well as those granted emeriti professor status and service recognition.
The George Washington University has tapped Michael K. Rosner, MD, professor of Neurological Surgery, to serve as the interim chair of the GW Department of Neurological Surgery.
George Washington University researchers have identified a key molecule in certain kinds of breast cancers that prevent immune cells from entering tumors and killing the cancer cells inside. The paper and its findings, published today in Nature, could pave the way toward a new treatment for certain kinds of aggressive breast cancer.
